Medication treatment for opioid use disorder in expectant mothers (MOMs): Design considerations for a pragmatic randomized trial comparing extended-release and daily buprenorphine formulations
- Theresa Winhusen
- , Michelle Lofwall
- , Hendrée E. Jones
- , Christine Wilder
- , Robert Lindblad
- , Davida M. Schiff
- , Scott Wexelblatt
- , Stephanie Merhar
- , Sean M. Murphy
- , Shelly F. Greenfield
- , Mishka Terplan
- , Elisha M. Wachman
- , Frankie Kropp
- , Jeff Theobald
- , Mitra Lewis
- , Abigail G. Matthews
- , Connie Guille
- , Michael Silverstein
- , Carmen Rosa
Producción científica: Article › revisión exhaustiva
36
Citas
(Scopus)